Skip to Content

 Your industry is next.


GDPR fines have crossed €7.1 billion. HIPAA enforcement is rising. The EU AI Act is now in force. And regulators have moved past Big Tech to the exact industries Boston BizTech serves — healthcare, financial services, life sciences, and higher ed.

Download the whitepaper to see what the fines actually look like, who is paying them, and what a compliance program built to withstand real scrutiny requires.


Download the Free Whitepaper

"Your Technology Should Be An Asset — Not A Ransom Note." 

Why This Matters Now


For years, the biggest privacy fines landed almost exclusively on Big Tech: Meta, Google, TikTok, LinkedIn. That's no longer where enforcement is concentrated. Regulators have spent the last two years building confidence — and budget — to go after mid-sized organizations across finance, healthcare, energy, and telecommunications. Company size has never been an exemption, and it isn't becoming one.

At the same time, the compliance map itself has gotten more complicated. Twenty US states now have comprehensive privacy laws on the books. The EU AI Act adds an entirely new obligation on top of existing data privacy law — one most mid-market companies haven't assessed, often because the AI features triggering it arrived quietly, bundled into a SaaS platform update.

This whitepaper walks through what's actually happening across GDPR, HIPAA, CCPA/CPRA, and the EU AI Act — in plain terms, with the real enforcement numbers — and lays out the three questions every credible compliance program has to be able to answer.

What's Inside the Whitepaper

The current enforcement landscape

Why the scope of GDPR, HIPAA, and CCPA fines has widened past Big Tech, and what that means if you've assumed you're too small to be noticed.

HIPAA's enforcement trend

The structural gaps (missing risk analysis, outdated business associate agreements, unaudited infrastructure) that show up again and again in real cases.

CCPA/CPRA and the expanding US state privacy landscape

What changes now that 20 states have comprehensive privacy laws.

The EU AI Act

The compliance obligation most mid-market companies haven't assessed yet, and how AI features already embedded in your existing tools may have put you in scope.

The Three Questions

The three questions your compliance program must be able to answer, with documented, auditable evidence.

A Real Case Studies

How Boston BizTech rebuilt a clinical research company's infrastructure and compliance program ahead of an FDA audit — without shutting the business down.

  Download the Whitepaper 

Who This Is For


Built for CEOs, CFOs, and IT leaders at mid-market organizations in pharma and biotech, financial services, higher education, and any business handling regulated personal data — particularly if you've never had a documented answer to “what happens to our data, and who's accountable for it.”

BOSTON BIZTECH CASE STUDY

A clinical research client came to us running critical clinical data on infrastructure with no formal security implementation, no documentation, and no history of being audited against HIPAA. Facing an FDA audit, they were at real risk of shutdown. We rebuilt the infrastructure to enterprise standards, rewrote IT procedures for FDA, HIPAA, and GDPR compliance, and stood up vCISO and Fractional DPO programs. Result: multiple audits passed, and new clinical trial contracts won.

NOT SURE WHERE YOU STAND?

Ready to find out what your actual exposure looks like?


Schedule a free 30-minute discovery call. We'll walk through the frameworks that apply to your business and where the real gaps are — before a regulator finds them first.


 SCHEDULE YOUR DISCOVERY CALL